Latest papers

Novel Agents and Future Directions for Refractory Breast Cancer

Targeting mTOR for the treatment of AML. New agents and new directions.

Bending the cost curve in cancer care.

[Follow-up of cancer survivors: a shared responsibility].

Reflections of Myles. LID - 10.3928/00904481-20110412-10 [doi] FAU - Moffett, Kathryn S AU - Moffett KS LA - eng PT - Case Reports PT - Journal Article PL - United States TA - Pediatr Ann JT - Pediatric annals JID - 0356657 SB - IM MHDA- 2011/07/01 06:00 AID - 10.3928/00904481-20110412-10 [doi] PST - ppublish SO - Pediatr Ann. 2011 May;40(5):282-3. doi: 10.3928/00904481-20110412-10.

Abstracts of the Excellence in Oncology 2010 Conference. November 18-20, 2010. Athens, Greece.

[Cancer of the thyroid gland: the history of studying at the period from the XIX to the middle of the XX century].

[Statistical models of longevity, aging and degradation in demography, gerontology and oncology].

Understanding bereavement: what every oncology practitioner should know.

Providing Pain and Palliative Care Education Internationally

Biologic and surgical challenge of colorectal hepatic metastases. Seminar dedicated to Dr. Leslie Blumgart and Dr. Henri Bismuth.

[Actualities in prostate cancer in ASCO annual meeting 2010].

[Following communications made at American Society of Clinical Oncology 2010, what will change our practice? The point of view of the editorial board of Bulletin du Cancer].

The tipping point: it's time for oncologists to prepare for change.

Projecting the need for gynecologic oncologists for the next 40 years.

$2.16 billion boost: McKesson builds portfolio with US Oncology.

A prospective study of the clinical impact of a multidisciplinary head and neck tumor board.

[The biology of cancer: a decade's assessment].

Current world literature.

[Papillomavirus and cancer: new lights].